Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: Anthony@Pacific who wrote (4059)	1/14/1999 4:45:00 PM
From: T-Lo Greens	Read Replies (1) \| Respond to of 122087

Hahaha Anthony are you messing with me? Well I'll re-short tomorrow then. It looked kind of weak today, but firmed up near the close so I was glad to get out with minimal damage - just a few ruffled feathers and bruised ego, but besides that everything's fine. =) Hope everyone had a great day shorting. Toneo P.S. I'll go by Toneo from now on so people won't mistake us.

To: Anthony@Pacific who wrote (4059)	1/14/1999 5:12:00 PM
From: glen	Read Replies (2) \| Respond to of 122087

Anthony-Check out CYTL as a possible short candidate. Up today due to report on positive results in animal tests of possible Aids vaccine. However, they are at least 5 years away from any tangible, and marketable vaccine. AIDSVAX vaccine, which is already in Phase III Clinical trials, is years ahead of ANY other biotech firm doing vaccine research in this area. BTW, VAXGEN Inc., currently a private company, and 25% owned by Genen Tech, holds the patents on the AIDSVAX vaccine. Bottom line for CYTL is that the news today is even more remote of any economic benefit than is the news yesterday of KERA. I have no position in CYTL (i.e. yet) but it should work it's way back down to 3, IMHO. Regards, glen